Physician profile
Amanda E Macone
NPI 1356760821
$2,598.46
in general payments reported to CMS, 2019-2025
10 companies · $1,073 in 2025
The $1,073 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2021: $196 · 2022: $261 · 2023: $340 · 2024: $616 · 2025: $1,073.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,029.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,028.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $926.94 | 2021-2025 | Vyepti |
| Abbvie INC. | $509.67 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $289.36 | 2023-2025 | Ajovy |
| Pfizer INC. | $190.47 | 2023-2025 | |
| Tonix Medicines, INC. | $180.65 | 2023 | |
| Impel Pharmaceuticals INC. | $136.52 | 2022 | |
| Axsome Therapeutics, INC. | $127.82 | 2025 | |
| Allergan, INC. | $112.88 | 2019 | |
| Lilly USA, LLC | $84.11 | 2022 | |
| Amgen INC. | $40.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Macone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.